查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1754828

藥物濫用（DOA）檢測市場：2034 年的機會與策略

Drugs Of Abuse (DOA) Testing Global Market Opportunities And Strategies To 2034
出版日期: | 出版商: The Business Research Company | 英文 325 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2019 年全球藥物濫用 (DOA) 檢測市場價值為 53.934 億美元，到 2024 年複合年成長率將超過 6.00%。

吸毒案例增多

歷史時期藥物濫用檢測市場的成長是由藥物濫用案例的增加所推動的。藥物濫用案例是指個人過量或不當使用非法藥物、處方藥或其他有害物質等物質，導致身體、心理或社會傷害的情況。藥物濫用案件的增加通常與精神健康問題惡化有關，因為許多人轉向使用鴉片類藥物和大麻等物質來應對焦慮、憂鬱和情緒困擾等狀況。對藥物濫用檢測的需求是由雇主、醫療保健提供者、執法機構和教育機構需要監測、檢測和防止藥物濫用，以維護安全、合規和公共健康所驅動的。例如，根據英國政府機構國家統計局的數據，截至2023年3月底的一年中，約有9.5%（約310萬人）的16至59歲人口報告使用過毒品。其中，7.6%（約250萬人）報告曾使用大麻，3.3%（約110萬人）報告曾使用A類毒品。因此，藥物濫用案例的增加正顯著促進藥物濫用檢測市場的擴張。

目錄

第1章執行摘要

  • 藥物濫用（DOA）檢測－市場吸引力與宏觀經濟條件

第 2 章目錄

第3章表格一覽

第4章圖表一覽

第5章 報告結構

第6章 市場特徵

  • 一般市場定義
  • 概述
  • 藥物濫用（DOA）檢測市場定義和細分
  • 市場區隔：按產品和服務
    • 分析儀
    • 快速檢測裝置
    • 耗材
    • 化驗服務
  • 市場區隔：依樣品類型
    • 尿
    • 頭髮
    • 口腔液體
    • 呼吸
    • 其他樣本類型
  • 按應用程式細分市場
    • 疼痛管理
    • 刑事司法
    • 職場篩檢
  • 市場區隔：按最終用戶
    • 醫院
    • 診斷實驗室
    • 法醫學研究所
    • 其他最終用戶

第7章：主要市場趨勢

  • 利用質譜解決方案革新藥物檢測，提高準確性與效率
  • 創新藥物濫用試劑提高檢測準確性和便攜性
  • 提高尿液藥物濫用檢測的準確性並擴大快速檢測

第8章 全球濫用藥物（DOA）檢測成長分析與策略分析框架

  • 全球濫用藥物（DOA）檢測的PESTEL分析（政治、社會、技術、環境和法律因素）
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 環境
    • 合法地
  • 最終用戶分析（B2B）
    • 醫院
    • 診斷實驗室
    • 法醫學研究所
    • 其他最終用戶
  • 全球藥物濫用（DOA）檢測市場：成長率分析
  • 2019-2024年市場成長表現
    • 2019-2024年市場促進因素
    • 2019-2024年市場限制
  • 2024-2029年及2034年市場成長預測
    • 2024-2029年市場促進因素
    • 2024-2029年市場限制
  • 影響成長預測的因素
    • 量化成長的貢獻者
    • 驅動程式
    • 限制因素
  • 全球濫用藥物 (DOA) 檢測總可用市場 (TAM)

9. 全球濫用藥物（DOA）檢測市場區隔

  • 全球藥物濫用 (DOA) 檢測市場（按產品和服務、績效及預測）2019-2024 年、2029 年及 2034 年
  • 全球濫用藥物 (DOA) 檢測市場（按樣本類型、表現和預測）2019-2024 年、2029 年和 2034 年
  • 全球藥物濫用 (DOA) 檢測市場的應用、表現及預測（2019-2024 年、2029 年及 2034 年）
  • 全球濫用藥物 (DOA) 檢測市場（按最終用戶、績效及預測）2019-2024 年、2029 年及 2034 年
  • 全球藥物濫用 (DOA) 檢測市場、分析儀器細分、類型、性能及預測（2019-2024 年、2029 年及 2034 年）
  • 全球濫用藥物 (DOA) 檢測市場，快速檢測設備細分，按類型、性能和預測，2019-2024 年、2029 年、2034 年
  • 全球濫用藥物 (DOA) 檢測市場、消耗品細分、類型、績效及預測（2019-2024 年、2029 年及 2034 年）
  • 全球濫用藥物 (DOA) 檢測市場，按檢測服務細分，按類型、績效及預測，2019-2024 年、2029 年及 2034 年

第 10 章。藥物濫用（DOA）檢測市場：區域和國家分析

  • 全球藥物濫用 (DOA) 檢測市場：按地區、績效及預測，2019-2024 年、2029 年及 2034 年
  • 全球藥物濫用 (DOA) 檢測市場：按國家/地區、績效及預測，2019-2024 年、2029 年及 2034 年

第11章 亞太市場

第12章 西歐市場

第13章 東歐市場

第14章 北美市場

第15章 南美洲市場

第16章 中東市場

第17章：非洲市場

第18章 競爭格局及公司概況

  • 公司簡介
  • Abbott Laboratories
  • Danaher Corporation（Beckman Coulter）
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Inc.
  • Thermo Fisher Scientific Inc.

第19章 其他大型創新企業

  • F. Hoffmann-La Roche Ltd.
  • Dragerwerk AG & Co. KGaA
  • Siemens Healthneers
  • Bio-Rad Laboratories Inc.
  • Agilent Technologies Inc.
  • HireRight Holdings Corporation.
  • Sonic Healthcare Limited
  • LGC Limited
  • DISA Global Solutions Inc.
  • Randox Laboratories Ltd.
  • Intoximeters Inc.
  • First Advantage Corporation
  • Cordant Health Solutions
  • Precision Diagnostics LLC
  • Omega Laboratories Inc.

第20章 競爭基準化分析

第 21 章 競爭儀錶板

第22章 重大併購

  • Premier Biotech Inc., Acquired Desert Tox LLC
  • Aegis Sciences Corporation Acquires Healthtrackrx's Toxicology Business

第23章藥物濫用檢測市場的最新趨勢

第24章機會與策略

  • 2029 年全球濫用藥物 (DOA) 檢測市場：提供新機會的國家
  • 2029 年全球濫用藥物 (DOA) 檢測市場：細分市場帶來新機會
  • 2029 年全球濫用藥物 (DOA) 檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第 25 章藥物濫用（DOA）檢測市場：結論與建議

  • 結論
  • 建議
    • 產品
    • 地方
    • 價格
    • 晉升
    • 人們

第26章 附錄

簡介目錄
Product Code: o&s1637

Drugs of Abuse (DOA) testing refers to the process of detecting the presence of illicit substances or misused prescription medications in an individual's system. This testing is utilized by various entities, including employers, law enforcement agencies, healthcare providers and educational institutions, to ensure safety, compliance with regulations and to provide appropriate medical interventions.

The drugs of abuse (DOA) testing market consists of sales, by entities (organizations, sole traders, or partnerships), of drugs of abuse (DOA) testing software and services used in workplaces, law enforcement, healthcare and rehabilitation programs to identify drug use, ensure compliance with regulations and support medical or legal decisions.

The global drugs of abuse (DOA) testing market was valued at $5,393.40 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 6.00%.

Rising Drug Abuse Cases

The growth of the drugs of abuse testing market during the historic period has been driven by the rising drug abuse cases. Drug abuse cases refer to situations where individuals excessively or improperly use substances such as illegal drugs, prescription medications, or other harmful substances, leading to physical, psychological, or social harm. Increasing drug abuse cases are often associated with escalating mental health issues, as many individuals resort to substances like opioids or cannabis to cope with conditions such as anxiety, depression, or emotional distress. The demand for drugs of abuse testing is propelled by the need for monitoring, detection, and prevention of substance misuse by employers, healthcare providers, law enforcement agencies, and educational institutions to maintain safety, compliance, and public health. For example, according to the Office for National Statistics, a UK-based government department, approximately 9.5% of individuals aged 16 to 59 years (around 3.1 million people) reported using drugs in the year ending March 2023. Among them, 7.6% reported cannabis use (around 2.5 million people), while 3.3% reported using Class A drugs (about 1.1 million people). Therefore, the increasing prevalence of drug abuse cases has significantly contributed to the expansion of the drugs of abuse testing market.

Revolutionizing Drug Testing With Mass Spec Solution For Enhanced Accuracy And Efficiency

Leading companies in the drugs of abuse testing market are focusing on developing innovative solutions, such as mass spec solutions, to enhance the accuracy, sensitivity, and speed of drug testing processes. Mass Spec solution in drugs of abuse testing refers to the use of mass spectrometry (MS) technology for detecting and quantifying drugs and their metabolites in various biological samples, such as blood, urine, saliva, and hair. For instance, in December 2024, Roche Holding AG, a Switzerland-based pharmaceutical company, launched its cobas Mass Spec solution, which has received CE mark approval, marking a significant milestone in making clinical mass spectrometry widely available. This solution includes the cobas i 601 analyzer and the first Ionify reagent pack, enabling automated and standardized testing for over 60 analytes, including steroid hormones, vitamin D metabolites, and drugs of abuse. By integrating various technologies into a single platform, Roche aims to enhance diagnostic accuracy and efficiency in routine laboratories, facilitating earlier detection of therapeutic changes in patients. The cobas Mass Spec solution is expected to transform clinical diagnostics by providing faster, more precise results, ultimately improving patient care worldwide.

The global drugs of abuse (DOA) testing market is concentrated, with large players operating in the market. The top ten competitors in the market made up to 43.59% of the total market in 2023.

Drugs Of Abuse (DOA) Testing Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global drugs of abuse (DOA) testing market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for drugs of abuse (DOA) testing? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The drugs of abuse (DOA) testing market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider drugs of abuse (DOA) testing market; and compares it with other markets.

The report covers the following chapters

  • Introduction And Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product and service, by sample type, by application and by end-user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Growth Analysis And Strategic Analysis- Framework Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
  • Global Market Size And Growth - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods
  • Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by product and service, by sample type, by application and by end-user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market- Size And Growth Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers And Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Recent Developments- Information on recent developments in the market covered in the report.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for drugs of abuse (DOA) testing providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
  • Markets Covered:
  • 1) By Product And Service: Analyzers; Rapid Testing Devices; Consumables; Laboratory Services
  • 2) By Sample Type: Urine; Hair; Oral Fluid; Breath; Other Sample Types
  • 3) By Application: Pain Management; Criminal Justice; Workplace Screening
  • 4) By End User: Hospitals; Diagnostics Laboratories; Forensic Laboratories; Other End Users
  • Companies Mentioned: Abbott Laboratories; Danaher Corporation (Beckman Coulter); Laboratory Corporation of America Holdings; Quest Diagnostics Inc.; Thermo Fisher Scientific Inc.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; drugs of abuse (DOA) testing indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Drugs Of Abuse (DOA) Testing - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Drugs Of Abuse (DOA) Testing Market Definition And Segmentations
  • 6.4 Market Segmentation By Product And Service
    • 6.4.1 Analyzers
    • 6.4.2 Rapid Testing Devices
    • 6.4.3 Consumables
    • 6.4.4 Laboratory Services
  • 6.5 Market Segmentation By Sample Type
    • 6.5.1 Urine
    • 6.5.2 Hair
    • 6.5.3 Oral Fluid
    • 6.5.4 Breath
    • 6.5.5 Other Sample Types
  • 6.6 Market Segmentation By Application
    • 6.6.1 Pain Management
    • 6.6.2 Criminal Justice
    • 6.6.3 Workplace Screening
  • 6.7 Market Segmentation By End-User
    • 6.7.1 Hospitals
    • 6.7.2 Diagnostic Laboratories
    • 6.7.3 Forensic Laboratories
    • 6.7.4 Other End-Users

7 Major Market Trends

  • 7.1 Revolutionizing Drug Testing With Mass Spec Solution For Enhanced Accuracy And Efficiency
  • 7.2 Innovative Drugs Of Abuse Reagents Enhance Accuracy And Portability In Testing
  • 7.3 Expansion Of Urine Drugs Of Abuse Testing For Enhanced Accuracy And Rapid Detection

8 Global Drugs Of Abuse (DOA) Testing Growth Analysis And Strategic Analysis Framework

  • 8.1 Global Drugs Of Abuse (DOA) Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)
    • 8.1.1 Political
    • 8.1.2 Economic
    • 8.1.3 Social
    • 8.1.4 Technological
    • 8.1.5 Environmental
    • 8.1.6 Legal
  • 8.2 Analysis Of End-Users (B2B)
    • 8.2.1 Hospitals
    • 8.2.2 Diagnostic Laboratories
    • 8.2.3 Forensic Laboratories
    • 8.2.4 Other End-Users
  • 8.3 Global Drugs Of Abuse (DOA) Testing Market Growth Rate Analysis
  • 8.4 Historic Market Growth, 2019 - 2024, Value ($ Million)
    • 8.4.1 Market Drivers 2019 - 2024
    • 8.4.2 Market Restraints 2019 - 2024
  • 8.5 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
    • 8.5.1 Market Drivers 2024 - 2029
    • 8.5.2 Market Restraints 2024 - 2029
  • 8.6 Forecast Growth Contributors/Factors
    • 8.6.1 Quantitative Growth Contributors
    • 8.6.2 Drivers
    • 8.6.3 Restraints
  • 8.7 Global Drugs Of Abuse (DOA) Testing Total Addressable Market (TAM)

9 Global Drugs Of Abuse (DOA) Testing Market Segmentation

  • 9.1 Global Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.2 Global Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.3 Global Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.4 Global Drugs Of Abuse (DOA) Testing Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.5 Global Drugs Of Abuse (DOA) Testing Market, Sub-Segmentation Of Analyzers, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.6 Global Drugs Of Abuse (DOA) Testing Market, Sub-Segmentation Of Rapid Testing Devices, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.7 Global Drugs Of Abuse (DOA) Testing Market, Sub-Segmentation Of Consumables, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.8 Global Drugs Of Abuse (DOA) Testing Market, Sub-Segmentation Of Laboratory Services, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 Drugs Of Abuse (DOA) Testing Market, Regional and Country Analysis

  • 10.1 Global Drugs Of Abuse (DOA) Testing Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.2 Global Drugs Of Abuse (DOA) Testing Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

  • 11.1 Summary
  • 11.2 Market Overview
    • 11.2.1 Region Information
    • 11.2.2 Market Information
    • 11.2.3 Background Information
    • 11.2.4 Government Initiatives
    • 11.2.5 Regulations
    • 11.2.6 Regulatory Bodies
    • 11.2.7 Major Associations
    • 11.2.8 Taxes Levied
    • 11.2.9 Corporate Tax Structure
    • 11.2.10 Investments
    • 11.2.11 Major Companies
  • 11.3 Asia-Pacific Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.4 Asia-Pacific Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.5 Asia-Pacific Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.6 Asia-Pacific Drugs Of Abuse (DOA) Testing Market: Country Analysis
  • 11.7 China Market
  • 11.8 Summary
  • 11.9 Market Overview
    • 11.9.1 Country Information
    • 11.9.2 Market Information
    • 11.9.3 Background Information
    • 11.9.4 Government Initiatives
    • 11.9.5 Regulations
    • 11.9.6 Regulatory Bodies
    • 11.9.7 Major Associations
    • 11.9.8 Taxes Levied
    • 11.9.9 Corporate Tax Structure
    • 11.9.10 Major Companies
  • 11.10 China Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.11 China Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.12 China Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.13 India Market
  • 11.14 India Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.15 India Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.16 India Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.17 Japan Market
  • 11.18 Summary
  • 11.19 Market Overview
    • 11.19.1 Country Information
    • 11.19.2 Market Information
    • 11.19.3 Background Information
    • 11.19.4 Government Initiatives
    • 11.19.5 Regulations
    • 11.19.6 Regulatory Bodies
    • 11.19.7 Major Associations
    • 11.19.8 Taxes Levied
    • 11.19.9 Corporate Tax Structure
    • 11.19.10 Investments
    • 11.19.11 Major Companies
  • 11.20 Japan Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.21 Japan Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.22 Japan Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.23 Australia Market
  • 11.24 Australia Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.25 Australia Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.26 Australia Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.27 Indonesia Market
  • 11.28 Indonesia Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.29 Indonesia Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.30 Indonesia Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.31 South Korea Market
  • 11.32 Summary
  • 11.33 Market Overview
    • 11.33.1 Country Information
    • 11.33.2 Market Information
    • 11.33.3 Background Information
    • 11.33.4 Government Initiatives
    • 11.33.5 Regulations
    • 11.33.6 Regulatory Bodies
    • 11.33.7 Major Associations
    • 11.33.8 Taxes Levied
    • 11.33.9 Corporate Tax Structure
    • 11.33.10 Major Companies
  • 11.34 South Korea Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.35 South Korea Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.36 South Korea Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate tax structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Western Europe Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.4 Western Europe Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.5 Western Europe Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.6 Western Europe Drugs Of Abuse (DOA) Testing Market: Country Analysis
  • 12.7 UK Market
  • 12.8 UK Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.9 UK Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.10 UK Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.11 Germany Market
  • 12.12 Germany Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.13 Germany Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.14 Germany Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.15 France Market
  • 12.16 France Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.17 France Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.18 France Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.19 Italy Market
  • 12.20 Italy Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.21 Italy Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.22 Italy Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.23 Spain Market
  • 12.24 Spain Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.25 Spain Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.26 Spain Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate Tax Structure
    • 13.2.10 Major companies
  • 13.3 Eastern Europe Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.4 Eastern Europe Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.5 Eastern Europe Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.6 Eastern Europe Drugs Of Abuse (DOA) Testing Market: Country Analysis
  • 13.7 Russia Market
  • 13.8 Russia Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.9 Russia Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.10 Russia Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Investments
    • 14.2.11 Major Companies
  • 14.3 North America Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.4 North America Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.5 North America Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.6 North America Drugs Of Abuse (DOA) Testing Market: Country Analysis
  • 14.7 USA Market
  • 14.8 Summary
  • 14.9 Market Overview
    • 14.9.1 Country Information
    • 14.9.2 Market Information
    • 14.9.3 Background Information
    • 14.9.4 Government Initiatives
    • 14.9.5 Regulations
    • 14.9.6 Regulatory Bodies
    • 14.9.7 Major Associations
    • 14.9.8 Taxes Levied
    • 14.9.9 Corporate Tax Structure
    • 14.9.10 Investments
    • 14.9.11 Major Companies
  • 14.10 USA Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.11 USA Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.12 USA Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.13 Canada Market
  • 14.14 Summary
  • 14.15 Market Overview
    • 14.15.1 Country Information
    • 14.15.2 Market Information
    • 14.15.3 Background Information
    • 14.15.4 Government Initiatives
    • 14.15.5 Regulations
    • 14.15.6 Regulatory Bodies
    • 14.15.7 Major Associations
    • 14.15.8 Taxes Levied
    • 14.15.9 Corporate Tax Structure
    • 14.15.10 Investments
    • 14.15.11 Major Companies
  • 14.16 Canada Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.17 Canada Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.18 Canada Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Investments
    • 15.2.11 Major Companies
  • 15.3 South America Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.4 South America Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.5 South America Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.6 South America Drugs Of Abuse (DOA) Testing Market: Country Analysis
  • 15.7 Brazil Market
  • 15.8 Brazil Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.9 Brazil Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.10 Brazil Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Investments
    • 16.2.11 Major Companies
  • 16.3 Middle East Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.4 Middle East Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.5 Middle East Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Major Companies
  • 17.3 Africa Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.4 Africa Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.5 Africa Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

  • 18.1 Company Profiles
  • 18.2 Abbott Laboratories
    • 18.2.1 Company Overview
    • 18.2.2 Products And Services
    • 18.2.3 Financial Overview
  • 18.3 Danaher Corporation (Beckman Coulter)
    • 18.3.1 Company Overview
    • 18.3.2 Products And Services
    • 18.3.3 Financial Overview
  • 18.4 Laboratory Corporation of America Holdings
    • 18.4.1 Company Overview
    • 18.4.2 Products And Services
    • 18.4.3 Financial Overview
  • 18.5 Quest Diagnostics Inc.
    • 18.5.1 Company Overview
    • 18.5.2 Products And Services
    • 18.5.3 Business Strategy
    • 18.5.4 Financial Overview
  • 18.6 Thermo Fisher Scientific Inc.
    • 18.6.1 Company Overview
    • 18.6.2 Products And Services
    • 18.6.3 Business Strategy
    • 18.6.4 Financial Overview

19 Other Major And Innovative Companies

  • 19.1 F. Hoffmann-La Roche Ltd.
    • 19.1.1 Company Overview
    • 19.1.2 Products And Services
  • 19.2 Dragerwerk AG & Co. KGaA
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
  • 19.3 Siemens Healthneers
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
  • 19.4 Bio-Rad Laboratories Inc.
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
  • 19.5 Agilent Technologies Inc.
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
  • 19.6 HireRight Holdings Corporation.
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
  • 19.7 Sonic Healthcare Limited
    • 19.7.1 Company Overview
    • 19.7.2 Products And Services
  • 19.8 LGC Limited
    • 19.8.1 Company Overview
    • 19.8.2 Products And Services
  • 19.9 DISA Global Solutions Inc.
    • 19.9.1 Company Overview
    • 19.9.2 Products And Services
  • 19.10 Randox Laboratories Ltd.
    • 19.10.1 Company Overview
    • 19.10.2 Products And Services
  • 19.11 Intoximeters Inc.
    • 19.11.1 Company Overview
    • 19.11.2 Products And Services
  • 19.12 First Advantage Corporation
    • 19.12.1 Company Overview
    • 19.12.2 Products And Services
  • 19.13 Cordant Health Solutions
    • 19.13.1 Company Overview
    • 19.13.2 Products And Services
  • 19.14 Precision Diagnostics LLC
    • 19.14.1 Company Overview
    • 19.14.2 Products And Services
  • 19.15 Omega Laboratories Inc.
    • 19.15.1 Company Overview
    • 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Premier Biotech Inc., Acquired Desert Tox LLC
  • 22.2 Aegis Sciences Corporation Acquires Healthtrackrx's Toxicology Business

23 Recent Developments in the Drugs of Abuse Testing Market

  • 23.1 Dual Blood Marker Test Launched For Enhanced Alcohol Monitoring

24 Opportunities And Strategies

  • 24.1 Global Drugs Of Abuse (DOA) Testing Market In 2029 - Countries Offering Most New Opportunities
  • 24.2 Global Drugs Of Abuse (DOA) Testing Market In 2029 - Segments Offering Most New Opportunities
  • 24.3 Global Drugs Of Abuse (DOA) Testing Market In 2029 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Drugs Of Abuse (DOA) Testing Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer